To access this element change to forms mode OFF
Grant Award View - GA166508
Accelerated clinical development of a next generation COVID-19 vaccine...
GA ID:
GA166508
Agency:
Department of Health and Aged Care
Approval Date:
12-Feb-2021
Publish Date:
25-May-2021
Category:
Health and Medical Research
Grant Term:
1-Mar-2021 to 28-Feb-2023
Value (AUD):
$2,983,909.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_COVID-19_Vaccine_Candidate_Research_R2
Grant Activity:
Accelerated clinical development of a next generation COVID-19 vaccine using the established Sementis Copenhagen Vector platform system
Purpose:
In response to the global COVID-19 pandemic, the WHO have outlined the need for vaccines which can address outbreaks, and provide population scale vaccination for the longer term. Our COVID-19 vaccine, based on a novel next-generation non-replicating viral vector vaccine technology, is advanced in development, and designed to deliver safe, broad, and long-lasting immunity. It can be produced economically and at scale to support these large-scale national and global vaccination programs.
GO ID:
GO Title:
MRFF – 2020 COVID-19 Vaccine Candidate Research grant opportunity
Internal Reference ID:
MRF2007147
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of South Australia
Recipient ABN:
37 191 313 308
Grant Recipient Location
Suburb:
Mawson Lake
Town/City:
Mawson Lake
Postcode:
5095
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, SA
Postcode:
Multiple
Country:
AUSTRALIA